← Patent-cliff monitor small molecule NUZYRA OMADACYCLINE TOSYLATE
Loss of exclusivity October 2037 latest FDA-listed patent expiry
Drug detail Brand name NUZYRA Active ingredient OMADACYCLINE TOSYLATE Strength EQ 150MG BASE Dosage form TABLET Route ORAL Modality Small molecule FDA approval October 2018 Marketing status RX
Listed patents Patent Expires Type 10383884 October 2037 use U-2576 10835542 October 2037 use U-2576 10111890 August 2037 use U-2444 9314475 March 2031 product 9265740 October 2030 product 8383610 September 2030 substance 10124014 March 2029 use U-2449 9724358 March 2029 use U-1569
Regulatory exclusivity Code Expires M-320 May 2029 GAIN October 2028 NCE October 2023
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.